What is the recommended dosing of Monocef (ceftriaxone) for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Monocef (Ceftriaxone) Pediatric Dosing

For most pediatric infections, ceftriaxone should be dosed at 50-75 mg/kg/day given once daily or divided every 12 hours, with higher doses of 100 mg/kg/day reserved for meningitis and severe infections, not exceeding 4 grams daily. 1, 2

Age-Specific Dosing for Neonates

Neonatal dosing requires special attention to age and weight:

  • Neonates ≤7 days old: 50 mg/kg/day given every 24 hours 1
  • Neonates >7 days and ≤2000 g: 50 mg/kg/day given every 24 hours 1
  • Neonates >7 days and >2000 g: 50-75 mg/kg/day given every 24 hours 1

Critical contraindication: Never use ceftriaxone in hyperbilirubinemic neonates due to risk of bilirubin encephalopathy 1, 2

Infection-Specific Dosing for Children

Severe Infections Requiring Higher Doses

  • Bacterial meningitis: 100 mg/kg/day divided every 12-24 hours (maximum 4 g daily) 1, 2
  • Pneumococcal pneumonia with penicillin resistance (MIC ≥4.0 μg/mL): 100 mg/kg/day every 12-24 hours 1, 3
  • Gram-negative enteric bacilli infections: 100 mg/kg/day divided every 12 hours or 80 mg/kg/day every 24 hours (maximum 4 g daily) 1
  • Infective endocarditis (HACEK organisms): 100 mg/kg/day IV/IM once daily for 4 weeks (native valve) or 6 weeks (prosthetic valve) 1

Moderate to Severe Infections

  • Community-acquired pneumonia: 50-100 mg/kg/day given once daily or divided every 12-24 hours 1, 3
  • Skin and skin structure infections: 50-75 mg/kg/day given once daily or divided twice daily (maximum 2 g daily) 1, 2
  • Complicated intra-abdominal infections: 50-75 mg/kg/day given every 12-24 hours 1
  • Sepsis: 50-75 mg/kg/day given every 12-24 hours 1

Single-Dose Regimens

  • Acute bacterial otitis media: Single IM dose of 50 mg/kg (maximum 1 gram) 2
  • Uncomplicated gonococcal infections (<45 kg): 125 mg IM single dose 1
  • Gonococcal conjunctivitis (≤45 kg): 25-50 mg/kg IV or IM single dose (maximum 250 mg) 1

Extended Treatment Regimens

  • Gonococcal bacteremia or arthritis: 50 mg/kg/day given daily for 7 days 1

Administration Guidelines

Route and timing considerations:

  • Intravenous administration: Infuse over 30 minutes in children; 60 minutes in neonates to reduce bilirubin encephalopathy risk 2
  • Intramuscular administration: Inject deep into large muscle mass; counsel patients about significant pain associated with IM injection 1, 4
  • Concentration for IV: 10-40 mg/mL recommended, though lower concentrations may be used 2

Critical safety warning: Never use calcium-containing diluents (Ringer's solution, Hartmann's solution) as particulate formation can occur 4, 2

Maximum Dose Limitations

Pediatric doses should never exceed adult maximum doses of 4 grams daily, regardless of calculated weight-based dosing. 1, 2

Pathogen-Specific Considerations

When treating specific pathogens with known susceptibility:

  • Streptococcus pneumoniae (penicillin MIC <2.0 μg/mL): 50-100 mg/kg/day every 12-24 hours 3
  • Group A Streptococcus: 50-100 mg/kg/day every 12-24 hours 3
  • Haemophilus influenzae (β-lactamase producing): 50-100 mg/kg/day every 12-24 hours 3

Common Pitfalls to Avoid

  • Do not use in jaundiced neonates - absolute contraindication due to displacement of bilirubin from albumin 1
  • Avoid calcium-containing solutions - can cause fatal precipitation 4, 2
  • Do not mix with other antimicrobials - administer sequentially with thorough line flushing 2
  • Ensure adequate infusion time in neonates - 60 minutes required, not 30 minutes 2
  • Consider twice-daily dosing for critically ill children with estimated GFR >80 mL/min/1.73 m² or when treating less-susceptible pathogens (MIC ≥0.5 mg/L) to improve target attainment 5

References

Guideline

Pediatric Dosing of Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ceftriaxone Pediatric Dosage Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ceftriaxone Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.